Palvella Therapeutics 宣布推出 Qtorin™ 新产品候选者 Qtorin™ Pitavastatin,用于治疗一种罕见的慢性前癌性遗传皮肤疾病——扩散性浅表性光敏性角化病(Dsap),该疾病尚无 FDA 批准的治疗方案

美股速递
Nov 05

Palvella Therapeutics 宣布推出 Qtorin™ 新产品候选者 Qtorin™ Pitavastatin,用于治疗一种罕见的慢性前癌性遗传皮肤疾病——扩散性浅表性光敏性角化病(Dsap),该疾病尚无 FDA 批准的治疗方案

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10